John R. Stuelpnagel, Director at 10x Genomics, Inc. (TXG), sold 5,000 shares at $202.18 ($997K) on 2021-06-17, disclosed to the SEC on 2021-06-21.
Open-market sale of $997k TXG by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $190.97 | 100 | $19K | 1.9% |
| 2 | $191.97 | 100 | $19K | 1.9% |
| 3 | $195.30 | 200 | $39K | 3.9% |
| 4 | $196.75 | 400 | $79K | 7.9% |
| 5 | $197.75 | 500 | $99K | 9.9% |
| 6 | $199.30 | 600 |
| $120K |
| 12.0% |
| 7 | $200.23 | 1,700 | $340K | 34.1% |
| 8 | $201.03 | 1,000 | $201K | 20.2% |
| 9 | $202.18 | 300 | $61K | 6.1% |
| 10 | $203.42 | 100 | $20K | 2.0% |
| Total | $199.39 avg | 5,000 | $997K | 100% |
| Filing → |
| TXG | SELL | 2023-06-07 | $549K | — | Filing → |
| TXG | SELL | 2022-01-04 | $1.5M | — | Filing → |
| TXG | SELL | 2021-12-03 | $756K | — | Filing → |